| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Yes associated protein 1 | 0.432 | 0.808 | 1.00 |
|
phenotype | 0.400 | None | 0.955 | 1 | 0 | 2013 | 2020 | ||||||||
|
XPC complex subunit, DNA damage recognition and repair factor | 0.504 | 0.808 | 3.7E-11 |
|
phenotype | 0.310 | None | 1.000 | 1 | 0 | 2010 | 2016 | ||||||||
|
vimentin | 0.372 | 0.846 | 0.71 |
|
phenotype | 0.400 | None | 0.986 | 1 | 0 | 1997 | 2020 | ||||||||
|
vasoactive intestinal peptide | 0.437 | 0.846 | 4.2E-04 |
|
phenotype | 0.320 | None | 1.000 | 1 | 0 | 1995 | 2019 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
phenotype | 0.400 | None | 0.976 | 3 | 0 | 1994 | 2020 | ||||||||
|
ubiquitin C-terminal hydrolase L3 | 0.705 | 0.385 | 3.3E-08 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon | 0.530 | 0.692 | 0.98 |
|
phenotype | 0.340 | None | 1.000 | 1 | 0 | 2007 | 2018 | ||||||||
|
twist family bHLH transcription factor 1 | 0.397 | 0.846 | 0.34 |
|
phenotype | 0.400 | None | 0.980 | 1 | 0 | 2004 | 2019 | ||||||||
|
tumor protein p63 | 0.362 | 0.769 | 1.00 |
|
phenotype | 0.400 | None | 0.893 | 1 | 0 | 2001 | 2019 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
phenotype | 0.600 | None | 0.936 | 1 | 0 | 1991 | 2020 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
phenotype | 0.400 | None | 0.980 | 2 | 0 | 1990 | 2020 | ||||||||
|
tubulin folding cofactor B | 0.931 | 0.115 | 1.1E-02 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
tropomyosin 4 | 0.656 | 0.577 | 0.39 |
|
phenotype | 0.310 | None | 1.000 | 1 | 0 | 2007 | 2018 | ||||||||
|
transforming growth factor beta receptor 2 | 0.413 | 0.846 | 0.13 |
|
phenotype | 0.400 | None | 1.000 | 1 | 0 | 2001 | 2019 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
phenotype | 0.400 | None | 0.982 | 4 | 0 | 1994 | 2020 | ||||||||
|
toll like receptor 4 | 0.321 | 0.962 | 4.6E-09 |
|
phenotype | 0.400 | None | 1.000 | 1 | 0 | 2009 | 2020 | ||||||||
|
TNF superfamily member 10 | 0.413 | 0.885 | 0.13 |
|
phenotype | 0.400 | None | 1.000 | 1 | 0 | 2003 | 2019 | ||||||||
|
TNF alpha induced protein 8 | 0.601 | 0.500 | 0.38 |
|
phenotype | 0.360 | None | 0.833 | 1 | 0 | 1997 | 2018 | ||||||||
|
tissue factor pathway inhibitor 2 | 0.521 | 0.769 | 8.4E-04 |
|
phenotype | 0.400 | None | 1.000 | 1 | 0 | 2000 | 2019 | ||||||||
|
thymidine phosphorylase | 0.495 | 0.769 | 1.2E-04 |
|
phenotype | 0.400 | None | 0.960 | 1 | 0 | 1996 | 2019 | ||||||||
|
thioredoxin domain containing 5 | 0.615 | 0.577 | 4.9E-13 |
|
phenotype | 0.320 | None | 1.000 | 1 | 0 | 2007 | 2019 | ||||||||
|
thioredoxin | 0.447 | 0.885 | 0.20 |
|
phenotype | 0.390 | None | 1.000 | 1 | 0 | 2008 | 2018 | ||||||||
|
TGFB induced factor homeobox 1 | 0.588 | 0.769 | 1.0E-02 |
|
phenotype | 0.320 | None | 1.000 | 1 | 0 | 2015 | 2019 | ||||||||
|
T cell leukemia/lymphoma 1B | 0.561 | 0.500 | 1.0E-02 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
SWI/SNF complex antagonist associated with prostate cancer 1 | 0.751 | 0.192 |
|
phenotype | 0.330 | None | 1.000 | 1 | 0 | 2013 | 2018 |